RxDoctor Payments Data

Thomas Heffron, MD

Transplant Surgery · Denver, CONPI 1063522423

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (34.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $6,270 and has fallen 55.9% since, to $2,767 in 2025.

$18,161in general payments, 2019–2025

Across 116 payments — averaging $156.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$12K
  • Histosonics, Inc.$1K
  • Davol Inc.$1K
  • TELA Bio, Inc.$1K
  • Medtronic$909
  • Boston Scientific$786
  • plus $938 from 16 others

What the payments were for

  • Travel & lodging$5,51330%
  • Food & beverage$4,88927%
  • Education$6,25034%
  • Gifts$90%
  • Other$1,5008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,161 in reported general payments places this provider in the 80th percentile of 22 transplant surgery providers in Colorado.

See all transplant surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$54,014
Medicare patients
48
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus61$15,377
Mycophenolate Mofetil45$10,873
Mycophenolic AcidMycophenolate Sodium18$7,943
Ursodiol42$6,910
Entecavir12$6,737
Pantoprazole Sodium21$220
Gabapentin11$161
Prednisone21$123
Amlodipine Besylate19$100

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →